Ocular cicatricial pemphigoid

Cover Page

Cite item

Full Text

Abstract

In this article, pathogenesis, clinical features, as well as methods of diagnosis and treatment of ocular mucous membrane pemphigoid are described.

About the authors

V Potemkin Vitaly

FSBEI HE “Academician I.P. Pavlov First St Petersburg State Medical University” of the Ministry of Healthcare of Russia

Author for correspondence.
Email: potem@inbox.ru

PhD, assistant professor. Department of Ophthalmology

Russian Federation, Saint Petersburg, Russia

Olga A Marchenko

City Ophthalmologic Center of Saint Petersburg State Hospital No 2

Email: oamarchenko@yandex.ru

Ophthalmologist

Russian Federation, Saint Petersburg, Russia

Elena V Ageeva

FSBEI HE “Academician I.P. Pavlov First St Petersburg State Medical University” of the Ministry of Healthcare of Russia

Email: ageeva_elena@inbox.ru

resident. Department of Ophthalmology

Russian Federation, Saint Petersburg, Russia

Yuliya I Malakhova

FSBEI HE “Academician I.P. Pavlov First St Petersburg State Medical University” of the Ministry of Healthcare of Russia

Email: julia_lady_m@mail.ru

resident. Department of Ophthalmology

Russian Federation, Saint Petersburg, Russia

References

  1. Ahmed M, Zein G, Khawaja F, Foster CS. Ocular cicatricial pemphigoid pathogenesis, diagnosis and treatment. Prog Retin Eye Res. 2004;23:579-92. doi: 10.1016/j.preteyeres.2004.05.005.
  2. Bernauer W, Dart JKG, Elder MJ, eds. Cicatrising conjunctivitis. Basel, Switzerland: Karger; 1997.
  3. Chan LS. Mucous membrane pemphigoid. Clin Dermatol. 2001;19:703-11. doi: 10.1016/S0738-081X(00)00196-6.
  4. Chan LS, Ahmed AR, Anhalt GJ, et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol. 2002Mar;138(3):370-9. doi: 10.1001/archderm.138.3.370.
  5. DaCosta J. Ocular cicatricial pemphigoid masquerading as chronic conjunctivitis: a case report. Clinical Ophthalmology. 2012;6:2093-2095. doi: 10.2147/OPTH.S40319.
  6. Elder MJ, Lightman S, Dart JK. Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid. Br J Ophthalmol. 1995Mar;79(3):264-6.
  7. Elder MJ, Bernauer W, Leonard J, Dart JK. Progression of disease in ocular cicatricial pemphigoid. Br J Ophthalmol. 1996;80:292. doi: 10.1136/bjo.80.4.292.
  8. Faraj HG, Hoang-Xuan T. Chronic cicatrizing conjunctivitis. Curr Opin Ophthalmol. 2001Aug;12(4):250-7. doi: 10.1097/00055735-200108000-00003.
  9. Foster CS. Cicatricial pemphigoid. Trans Am Ophthalmol Soc. 1986;84:527-663.
  10. Foster CS, Wilson LA, Ekins MB. Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. Ophthalmology. 1982;89:340-53. doi: 10.1016/S0161-6420(82)34791-0.
  11. Hardy KM, Perry HO, Pingree GC, Kirby TJ Jr. Benign mucous membrane pemphigoid. Arch Dermatol. 1971;104:467-75. doi: 10.1001/archderm.1971.04000230009002.
  12. Holland EJ, Olsen TW, Ketcham JM, et al. Topical cyclosporin A in the treatment of anterior segment inflammatory disease. Cornea. 1993 Sep;12(5):413-9. doi: 10.1097/00003226-199309000-00008.
  13. Jabs DA, Anhalt GJ. Cicatricial pemphigoid. In: Provost TT, Farmer ER, eds. Current therapy in dermatology. 2nd ed. Philadelphia: B.C. Decker; 1988. 56-7 pp.
  14. Kirzhner M, Jakobiec FA. Ocular cicatricial pemphigoid: a review of clinical features, immunopathology, differential diagnosis, and current management. Semin Ophthalmol. 2011;26(4-5):270-277. doi: 10.3109/08820538.2011.588660.
  15. Lambiase A, Micera A, Mantelli F, et al. T-helper 17 lymphocytes in ocular cicatricial pemphigoid. Molecular Vision. 2009;15:1449-1455.
  16. McCluskey P, Chang JH, Singh R, Wakefield D. Methotrexate therapy for ocular cicatricial pemphigoid. Ophthalmology. 2004Apr;111(4):796-80. doi: 10.1016/j.ophtha.2003.07.010.
  17. Mondino BJ, Brown SI. Ocular cicatricial pemphigoid. Ophthalmology. 1981;88:95-100. doi: 10.1016/S0161-6420(81)35069-6.
  18. Mondino BJ, Brown SI. Immunosuppressive therapy in ocular cicatricial pemphigoid. Am J Ophthalmol. 1983;96:453-9. doi: 10.1016/S0002-9394(14)77908-5.
  19. Messmer EM, Hintschich CR, Partscht K, et al. Ocular cicatricial pemphigoid. Retrospective analysis of risk factors and complications. Ophthalmologe. 2000Feb;97(2):113-20. doi: 10.1007/s003470050021.
  20. Miserocchi E, Baltatzis S, Roque MR. The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid. Ophthalmology. 2002Jan;109(1):111. doi: 10.1016/S0161-6420(01)00863-6.
  21. Razzaque MS, Foster CS, Ahmed AR. Tissue and molecular events in human conjunctival scarring in ocular cicatricial pemphigoid. Histol Histopathol. 2001;16:1203-12.
  22. Saw VPJ, Offiah I, Dart RJ, et al. Conjunctival Interleukin-13 Expression in Mucous Membrane Pemphigoid and Functional Effects of Interleukin-13 on Conjunctival Fibroblasts in vitro. Am J Pathol. 2009;175(6):2406-2415. doi: 10.2353/ajpath.2009.090579.
  23. Saw VPJ, Schmidt E, Offiah I, et al. Profibrotic phenotype of conjunctival fibroblasts from mucous membrane pemphigoid. Am J Pathol. 2011;178(1):187-197. doi: 10.1016/j.ajpath.2010.11.013.
  24. Thorne JE, Anhalt GJ, Jabs DA. Mucus membrane pemphigoid and pseudopemphigoid. Ophthalmology. 2004;111:45-52. doi: 10.1016/j.ophtha.2003.03.001.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Vitaly V.P., Marchenko O.A., Ageeva E.V., Malakhova Y.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies